Showing 1 - 3 results of 3 for search 'Daphne W. Bell', query time: 0.01s Refine Results
  1. 1
    The endometrial cancer A230V-ALK5 (TGFBR1) mutant attenuates TGF-β signaling and exhibits reduced in vitro sensitivity to ALK5 inhibitors.

    The endometrial cancer A230V-ALK5 (TGFBR1) mutant attenuates TGF-β signaling and exhibits reduced in vitro sensitivity to ALK5 inhibitors. by Eun-Jeong Yu, Daphne W Bell

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Proteomic Changes Associated With Endogenous FBXW7 Mutations in Moderately Differentiated Endometrial Cancer Cells Include Increased TROP2 and Galectin‐3 Levels

    Proteomic Changes Associated With Endogenous FBXW7 Mutations in Moderately Differentiated Endometrial Cancer Cells Include Increased TROP2 and Galectin‐3 Levels by Mary Ellen Urick, Suresh Kumar Chalapareddy, Eun‐Jeong Yu, Daphne W. Bell

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas.

    KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas. by Meghan L Rudd, Nancy F Hansen, Xiaolu Zhang, Mary Ellen Urick, Suiyuan Zhang, Maria J Merino, National Institutes of Health Intramural Sequencing Center Comparative Sequencing Program, James C Mullikin, Lawrence C Brody, Daphne W Bell

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: